BZW1 Inhibitors

BZW1, also known as BZW2 or TRIP-Br2, is a transcriptional regulator implicated in cell proliferation, differentiation, and tumorigenesis. This protein functions as a transcriptional coactivator, interacting with various transcription factors to modulate the expression of genes involved in cell cycle progression and oncogenesis. Through its association with transcription factors such as E2F, BZW1 exerts control over the transcriptional machinery, influencing the expression of genes crucial for cell proliferation and survival.

The inhibition of BZW1 is primarily achieved through targeting the insulin-like growth factor 1 receptor (IGF-1R) signaling pathway, which plays a pivotal role in regulating cell growth and proliferation. Chemical inhibitors targeting IGF-1R disrupt downstream signaling cascades involved in BZW1 expression, indirectly down-regulating its activity. By interfering with IGF-1R signaling, these inhibitors modulate the transcriptional landscape, ultimately leading to the inhibition of BZW1-mediated transcriptional coactivation. This inhibition strategy provides a promising avenue for the development of interventions targeting aberrant cell proliferation and oncogenic processes associated with dysregulated BZW1 activity.